ArticleThe Journal of infection2022

Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine.

Federico Gobbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.